157 related articles for article (PubMed ID: 25249292)
1. Ocular side effects and trichomegaly of eyelashes induced by erlotinib: a case report and review of the literature.
Celik T; Kosker M
Cont Lens Anterior Eye; 2015 Feb; 38(1):59-60. PubMed ID: 25249292
[TBL] [Abstract][Full Text] [Related]
2. Trichomegaly induced by erlotinib.
Papadopoulos R; Chasapi V; Bachariou A
Orbit; 2008; 27(4):329-30. PubMed ID: 18716976
[TBL] [Abstract][Full Text] [Related]
3. Erlotinib-induced trichomegaly in a male patient with pancreatic cancer.
Saif MW; Gnanaraj J
Cutan Ocul Toxicol; 2010 Mar; 29(1):62-6. PubMed ID: 19954400
[TBL] [Abstract][Full Text] [Related]
4. Trichomegaly secondary to erlotinib.
Desai RU; Rachakonda LP; Saffra NA
Can J Ophthalmol; 2009 Dec; 44(6):e65. PubMed ID: 20052001
[No Abstract] [Full Text] [Related]
5. Erlotinib-associated trichomegaly.
Lane K; Goldstein SM
Ophthalmic Plast Reconstr Surg; 2007; 23(1):65-6. PubMed ID: 17237698
[TBL] [Abstract][Full Text] [Related]
6. Acquired trichomegaly: trichomegaly secondary to erlotinib.
Medina Mendez CA; Ma PC; Singh AD
JAMA Ophthalmol; 2014 Sep; 132(9):1051. PubMed ID: 25078467
[No Abstract] [Full Text] [Related]
7. Persistent hair growth during treatment with the EGFR inhibitor erlotinib.
Alexandrescu DT; Kauffman CL; Dasanu CA
Dermatol Online J; 2009 Mar; 15(3):4. PubMed ID: 19379648
[TBL] [Abstract][Full Text] [Related]
8. Facial hypertrichosis and trichomegaly developing in patients treated with the epidermal growth factor receptor inhibitor erlotinib.
Vergou T; Stratigos AJ; Karapanagiotou EM; Matekovits AE; Dilana KD; Tsimboukis S; Antoniou C; Chasapi V; Syrigos KN
J Am Acad Dermatol; 2010 Aug; 63(2):e56-8. PubMed ID: 20633793
[No Abstract] [Full Text] [Related]
9. A case of trichomegaly of the eyelashes and facial hypertrichosis induced by erlotinib (Tarceva).
Márquez G; Herrera-Acosta E; Vidal I; Galvany L; Iglesias M; Umbert P
Int J Dermatol; 2009 Jan; 48(1):97-8. PubMed ID: 19126063
[No Abstract] [Full Text] [Related]
10. Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature.
Zhang G; Basti S; Jampol LM
Cornea; 2007 Aug; 26(7):858-60. PubMed ID: 17667622
[TBL] [Abstract][Full Text] [Related]
11. Erlotinib induced trichomegaly of the eyelashes.
Jeon SH; Ryu JS; Choi GS; Kim JS; Kwon HY; Kim MS; Nam HS; Cho JH; Kwak SM; Lee HL; Kim HJ; Hong GJ
Tuberc Respir Dis (Seoul); 2013 Jan; 74(1):37-40. PubMed ID: 23390452
[TBL] [Abstract][Full Text] [Related]
12. Cetuximab-associated elongation of the eyelashes: case report and review of eyelash trichomegaly secondary to epidermal growth factor receptor inhibitors.
Cohen PR; Escudier SM; Kurzrock R
Am J Clin Dermatol; 2011 Feb; 12(1):63-7. PubMed ID: 20726623
[TBL] [Abstract][Full Text] [Related]
13. Trichomegaly of the eyelashes after lung cancer treatment with the epidermal growth factor receptor inhibitor erlotinib.
Braiteh F; Kurzrock R; Johnson FM
J Clin Oncol; 2008 Jul; 26(20):3460-2. PubMed ID: 18612164
[No Abstract] [Full Text] [Related]
14. Eyelash trichomegaly induced by erlotinib for metastatic lung cancer.
Chan JYY; Kwok TYT; Yuen HKL
Hong Kong Med J; 2021 Feb; 27(1):60.e1-60.e3. PubMed ID: 33568562
[No Abstract] [Full Text] [Related]
15. Triad of trichomegaly, alopecia and male-pattern hair growth during treatment with erlotinib in non-small-cell lung cancer.
Forde P; Murphy C; O'Sullivan C; Carney D
Ir J Med Sci; 2011 Mar; 180(1):283-4. PubMed ID: 20108129
[TBL] [Abstract][Full Text] [Related]
16. Trichomegaly of the eyelashes during therapy with epidermal growth factor receptor inhibitors: report of 3 cases.
Fabbrocini G; Panariello L; Cacciapuoti S; Bianca D; Ayala F
Dermatitis; 2012; 23(5):237-8. PubMed ID: 23010833
[TBL] [Abstract][Full Text] [Related]
17. Epidermal Growth Factor Receptor Inhibitor Induced Trichomegaly and Poliosis.
Goyal S; Uwaydat SH
Ophthalmology; 2018 Feb; 125(2):294. PubMed ID: 29389408
[No Abstract] [Full Text] [Related]
18. Epidermal growth factor receptor-induced hirsutism and trichomegaly.
Munoz J; Hanbali AS
Mayo Clin Proc; 2011 Nov; 86(11):e50. PubMed ID: 22033260
[No Abstract] [Full Text] [Related]
19. Eyelash trichomegaly following treatment with erlotinib in a non-small cell lung cancer patient: A case report and literature review.
Wang SB; Lei KJ; Liu JP; Jia YM
Oncol Lett; 2015 Aug; 10(2):954-956. PubMed ID: 26622603
[TBL] [Abstract][Full Text] [Related]
20. Eyelash trichomegaly: review of congenital, acquired, and drug-associated etiologies for elongation of the eyelashes.
Paul LJ; Cohen PR; Kurzrock R
Int J Dermatol; 2012 Jun; 51(6):631-46; quiz 643-4, 646. PubMed ID: 22607279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
